local_hospital

Spitalul Clinic De Obstetrica Ginecologie Cuza Voda Iasi

Address
lock Available on a paid plan

Neonatology and Infant Respiratory Protection

At Spitalul Clinic De Obstetrica Ginecologie Cuza Voda Iasi, clinical research in neonatology includes studies focused on respiratory syncytial virus prevention in healthy infants. These trials are designed to assess whether a new preventive approach can reduce serious RSV-related lower respiratory infections while maintaining good safety and tolerability.

  • Prevention of RSV in infants
  • Evaluation of infection prevention and safety in early life
  • Research aimed at lowering medically attended respiratory illness

This work highlights the site’s interest in protecting newborns and young infants from common viral respiratory threats.

Eye Disease Research in Prematurity

The site also contributes to eye disease research through studies on retinopathy of prematurity, a serious condition affecting some preterm babies. The main goal is to follow long-term safety outcomes and visual function, helping determine how well treatment benefits may persist over time.

  • Retinopathy of prematurity
  • Long-term vision and safety follow-up
  • Research supporting better outcomes for premature infants

This area reflects an important focus on preserving vision and improving care for vulnerable newborns.

Women’s Health and Vaginal Infections

In female urogenital diseases, the research landscape includes trials for bacterial vaginosis and vulvovaginal candidiasis. These studies compare established treatments to better understand which options provide the most effective clinical and microbiological cure for women with vaginitis.

  • Bacterial vaginosis and vulvovaginal candidiasis
  • Treatment effectiveness in specific and non-specific vaginitis
  • Comparison of therapies used for vaginal infection control

This research supports improved management of common gynecological infections and aims to guide practical treatment choices in everyday care.

Infection and Immune-Related Clinical Research

Across its trial portfolio, the site also engages with bacterial infections and mycoses alongside immune system processes. These studies explore how preventive and therapeutic strategies can reduce infection burden and support better health outcomes in both infants and adult women.

  • Bacterial infections and fungal infections
  • Infection prevention and treatment response
  • Clinical research aimed at improving patient care

The work at this hospital-based research site shows a practical focus on common infectious conditions and their impact on vulnerable patient groups.

Site Overview

assignment
3
connected trials
corporate_fare
3
sponsors
science
4
IMPs

Activity Indicator

Last 6 months

0
Trials started
0
Trials started 6–12 months ago
3
Total trials linked
Moderately Active
trending_flatStable0%
Mar
Apr
May
Jun
Jul
Aug

Trial Flow

How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.

Therapeutic areaarrow_forwardIMParrow_forwardLifecycle status
lock Available on a paid plan

Compounds & Molecules Timeline

The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.

Trial span Ongoing Showing last 8 years
lock Available on a paid plan

Sponsor & Partnership

Top sponsors by active trials, and the ones that have come back for more than one study.

Active trials
1
Sponsors (total)
3
Active sponsors
1

Sponsor Network

Top 1 by active trials.

Partnership History

Sponsors with repeated collaboration (≥ 2 trials).

No repeated partnerships found.

Sponsor Network Graph

How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.

Country Benchmark

Compared to 442 other sites in Romania

description
Trial volume
3
Outperforms 50% of sites
public
Therapeutic diversity
4areas
Outperforms 82% of sites
groups
Sponsor diversity
3sponsors
Outperforms 55% of sites

Therapeutic Area Benchmark — Romania

Select a therapeutic area to compare against other sites in Romania.

Competitor Comparison

Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.

Country: Romania

Market Share

Country: Romania

Therapeutic Area Market Share

Select a therapeutic area to view its disease coverage breakdown.

Heat Maps & Advanced Analytics

How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.

Other Trials in Spitalul Clinic De Obstetrica Ginecologie Cuza Voda Iasi

lock Showing 1 of 3 trials — the rest is available on a paid plan.

Trial Sponsor Phase Status Start Date End Date
A Phase 2b/3 Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of MK-1654 in Healthy Pre-Term and Full-Term InfantsMerck Sharp & Dohme LLCPhase IVNot RecruitingNov 2022Feb 2024

IMP list

lock Showing 1 of 4 compounds — the rest is available on a paid plan.

IMP Trials Status First start Last start
Aflibercept1Unknown2020-03-272020-03-27

Upgrade this site to Business Plan

Own the profile, publish your feasibility data and reach sponsors directly.

Is something out of date?

Tell us what needs correcting and we'll update this profile.

lock Available to Business plan sites only.